From: B7H3-targeting chimeric antigen receptor modification enhances antitumor effect of Vγ9Vδ2 T cells in glioblastoma
WHO grade
Total Patients (n)
BTN2A1 Expression
Positive Rate (%)
BTN3A1 Expression
P Value
Positive (n)
Negative (n)
II
7
2
5
29
III
1
4
20
3
40
> 0.05
IV
14
6
8
43
50